SRI INTERNATIONAL - DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY

On Feb 18, 2026, Department of Health and Human Services obligated $9,754,263 to SRI INTERNATIONAL for decorporation mcm phase 1 clinical safety study. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in MENLO PARK, CA. The contract is scheduled through Apr 30, 2027 — approximately 8 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.